Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/20 16:33 | 10/27/20 | OPGN | Health | Health | Medical Laboratories | Jones Evan/ Fa | MD | D | S | -4 | 2.35 | 0 | -2 | -7 | 22 | I | |||||||||||||||
9/9/20 17:31 | 9/4/20 | OPGN | Health | Health | Medical Laboratories | Jones Evan/ Fa | MD | D | S | -8 | 2.19 | 0 | -4 | -13 | 23 | I | |||||||||||||||
5/11/20 14:35 | 5/7/20 | OPGN | Health | Health | Medical Laboratories | Curetis N.V. In Liquidation | 2M | T | S | 0 | 2.20 | 0 | 0 | -100 | 0 | D | |||||||||||||||
4/24/20 09:31 | 4/22/20 | OPGN | Health | Health | Medical Laboratories | Curetis N.V. In Liquidation | 2M | T | S.m | -196 | 2.20 | 0 | -89 | -5 | 1,623 | D | |||||||||||||||
4/21/20 20:09 | 4/17/20 | OPGN | Health | Health | Medical Laboratories | Curetis N.V. In Liquidation | 2M | T | S.m | -758 | 2.39 | 0 | -317 | -16 | 1,712 | D | |||||||||||||||
11/13/19 15:46 | 11/11/19 | OPGN | Health | Health | Medical Laboratories | Jones Evan/ Fa | MD | DO | CEO | S | 0 | 0.00 | 0 | -6 | -18 | 26 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |